PLYMOUTH MEETING, Pa. (WPVI) -- The TAVR procedure has revolutionized a challenging task in heart care: fixing stiff valves. And it has made the process much easier for patients, getting them back to ...

Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability. HealthDay News — Seven-year follow-up data show that transcatheter aortic-valve ...

Growing demand for a minimally invasive aortic valve replacement by adults under 65 with aortic stenosis may put many at ...

OSF HealthCare Foundation celebrated the completion of the 2,000th transcatheter aortic valve replacement (TAVR) procedure at ...

Veritas Aortic Solutions, an inQB8 spinout, raises $12M to advance non-surgical therapies for aortic root and ascending ...

Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate ...

For all the innovation, engineering, and miniaturization that has helped to refine surgical and transcatheter aortic valve replacement over the last few decades, they still fall short of ideal. That ...

To the Editor: In their article, Mack et al. (Nov. 23 issue) 1 imply that transcatheter aortic-valve replacement (TAVR) provides results that are similar to those of surgical aortic-valve replacement ...

The medical device giant just opened its wallet for a stake in a privately held company with a groundbreaking product.

Boston Scientific (NYSE:BSX) announced today that it invested $1.5 billion in transcatheter aortic valve replacement (TAVR) ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of Edward (Ed) Sarnowski as Chief Technology Officer. Ed ...